(Q43268228)

17 November 2017

Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease (English)

1 reference

17 November 2017

Markus van der Giet

1

1 reference

17 November 2017

Markus Tölle

2

1 reference

17 November 2017

Domenico Pratico

3

1 reference

17 November 2017

Volkmar Lufft

4

1 reference

17 November 2017

Mirjam Schuchardt

5

1 reference

17 November 2017

Matthias P Hörl

6

1 reference

17 November 2017

Walter Zidek

7

1 reference

17 November 2017

Uwe J F Tietge

8

1 reference

17 November 2017

2 October 2009

1 reference

Journal of Molecular Medicine

17 November 2017

1 reference

17 November 2017

88

1 reference

17 November 2017

1

1 reference

17 November 2017

75-83

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-009-0543-3

17 November 2017

0 references

cites work

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0543-3

Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris

21 January 2018

1 reference

12 December 2020

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

1 reference

12 December 2020

Phospholipase A(2) in vascular disease

1 reference

12 December 2020

Endothelial cell dysfunction: the syndrome in making

1 reference

12 December 2020

Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.

1 reference

12 December 2020

Kidney in early atherosclerosis

1 reference

12 December 2020

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

1 reference

12 December 2020

Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions

1 reference

12 December 2020

Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes

1 reference

12 December 2020

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

1 reference

12 December 2020

NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation

1 reference

12 December 2020

The clinical significance of endothelial dysfunction

1 reference

12 December 2020

Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide

1 reference

12 December 2020

Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries

1 reference

12 December 2020

Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle

1 reference

12 December 2020

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases

1 reference

12 December 2020

Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

12 December 2020

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

1 reference

12 December 2020

Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress

1 reference

12 December 2020

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

12 December 2020

Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I

1 reference

12 December 2020

Epidemiology of vascular disease in renal failure

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Lipolysis of LDL by Human Secretory Phospholipase A 2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans

1 reference

12 December 2020

Premature cardiovascular disease in chronic renal failure

1 reference

12 December 2020

HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism

1 reference

12 December 2020

Oxidative stress in uremia: nature, mechanisms, and potential consequences

1 reference

12 December 2020

Positive feedback regulation of COX-2 expression by prostaglandin metabolites

1 reference

12 December 2020

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function

1 reference

12 December 2020

A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver

1 reference

12 December 2020

Endothelial dysfunction and oxidative stress in chronic renal failure.

1 reference

12 December 2020

Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

1 reference

12 December 2020

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

1 reference

12 December 2020

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

1 reference

12 December 2020

Phospholipase A2 enzymes

1 reference

12 December 2020

Induction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions

1 reference

12 December 2020

10.1007/S00109-009-0543-3

Identifiers

DOI

1 reference

17 November 2017

1 reference